Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |